|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00099879 |
|
Date of registration:
|
21/12/2004 |
|
Primary sponsor: |
|
|
Public title:
|
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
|
|
Scientific title:
|
A Randomized, Two-Cohort Phase II Study of Two Doses of BMS-275183 Given on a Weekly Schedule in Patients With Pre-Treated Non-Small Cell Lung Cancer |
|
Date of first enrolment:
|
January 2004 |
|
Target sample size:
|
|
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00099879 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Belgium
|
France
|
Italy
|
Netherlands
|
Spain
|
United Kingdom
|
United States
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Advanced or metastatic pretreated NSCLC
- Measurable disease
- Adequate hematologic, hepatic and renal functions
- ECOG Performance Status of 0-2
Exclusion Criteria:
- Inability to swallow capsules
- Recent significant cardiovascular disease
- Woman who are pregnant or breastfeeding
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Non-small Cell Lung Cancer
|
|
Intervention(s)
|
|
Drug: BMS-275183
|
|
Secondary ID(s)
|
|
CA165-020
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|